- FDA approves Plan B One-Step OTC switch
- USPLabs agrees to recall and destroy dietary supplement following FDA actions
- FDA approves Iroko Pharmaceuticals NSAID
- Study: OTC ibuprofen as effective as Rx in treating post-operative pain after having tonsils removed
- Impax Labs, Tolmar receive FDA approval for generic version of Solaraze
PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic drug for arthritis made by Watson Pharmaceuticals, the company said.
Watson announced that the FDA approved a subsidiary's application for diclofenac sodium and misoprostol delayed-release tablets. The drug is a generic version of G.D. Searle's Arthrotec, used to treat osteoarthritis and rheumatoid arthritis in patients who have high risk of developing ulcers related to the use of non-steroidal anti-inflammatory drugs, or NSAIDs, a class that includes the painkiller ibuprofen.
Arthrotec had sales of about $130 million during the 12-month period ended in May, according to IMS Health data.